Kane Biotech Inc. KNBIF
Set alert
0.02 USD 0.00 0.00%
At close · Oct 30
0.0225 Day range 0.0225
0.01038 52-week range 0.0338
- YTD
- -15.41%
- 1 year
- -22.41%
- Open
- 0.0225
- Prev close
- 0.0225
- Mkt cap
- 4.61M
- Vol
- 10.00K
- Avg vol
- 134.65K
- EPS
- -0.01
- P/E
- 0.00
More statistics
- Low
- 0.0225
- High
- 0.0225
3M chart
Signals (26)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 27, 2026 | 6 days ago |
| SMA: Bullish | Oct 27, 2026 | 6 days ago |
| MACD: Buy Signal | Oct 26, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 19, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 15, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 13, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 6, 2026 | 3 weeks ago |
| MACD: Sell Signal | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 21, 2026 | 1 month ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 16, 2026 | 1 month ago |
| RSI: Oversold | Sep 4, 2026 | 1 month ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| SMA: Bullish | Aug 13, 2026 | 2 months ago |
| SMA: Bullish | Aug 12, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 10, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 4, 2026 | 3 months ago |
| SMA: Bearish | Aug 3, 2026 | 3 months ago |
News
- Kane Engages Independent Trading Group as Market Maker
- Kane Biotech Signs Distribution Agreement with The Stevens Company
- Kane to Showcase revyve® at Wounds Canada National Hybrid Conference
- Kane Launches New Corporate Brand and Redesigned Website
- Kane Biotech Announces $250,000 Insider Loan
- Kane Biotech to Present Clinical Data and Showcase revyve® Product Line at SAWC Fall 2026
- Kane Biotech Inc. (KNE:CA) Shareholder/Analyst Call Transcript
- Kane Biotech to Host Commercial Update Webcast on September 16
- Kane Biotech Announces Second Quarter 2026 Financial Results
- Kane Biotech Announces Engagement of DNA Advisors
Your note
Sign in to keep a note on KNBIF — it syncs with the Stock Master app.